entertainment -WSS

entertainment

author：fashion 2025-10-01 00:06:28 - browse：2121

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： First transplant of an entire human eye performed

entertainment

WSS

Judge agrees to delay next hearing in Trump classified documents case

Medicare’s new pay boost for primary care is angering specialists

Publishing genetic code of viruses could cause disaster

NIH chief: government has fallen behind pharma on clinical trials

Judge agrees to delay next hearing in Trump classified documents case

Medical school prerequisites are outdated

Wikipedia

entertainment

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

NIH chief: government has fallen behind pharma on clinical trials

Sports medicine is finally prioritizing gender equality

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Apple is now the first public company to be valued at $3 trillion

Recent heat wave in the Mediterranean caused by climate change: Study

In Memoriam: Notable people who died in 2023

Medical school prerequisites are outdated

Medical leaders decry Supreme Court decision on affirmative action

Wisconsin governor employs partial veto to fund schools for 4 centuries

hotspot

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

The U.S. needs a new definition of substance use “recovery”

Eisai exec who led development of Alzheimer’s drug to retire

White House drug czar issues call for 'recovery

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

What health policies could hitch a ride on a spending bill?

knowledge

entertainment

knowledge

focus